Loading: 100%
Ophthotech Corp. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 156 (as per Q2 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker OPHTno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17010203040
datesClosing price (adj.)
13.10.20172.63
11.10.20172.53
04.10.20172.60
27.09.20172.70
20.09.20172.79
13.09.20172.52
06.09.20173.11
30.08.20173.00
23.08.20172.80
16.08.20172.80
09.08.20172.66
02.08.20172.44
26.07.20172.71
19.07.20172.64
12.07.20172.69
05.07.20172.68
27.06.20172.70
20.06.20172.70
13.06.20172.55
06.06.20172.47
30.05.20172.33
23.05.20172.48
16.05.20172.64
09.05.20172.66
02.05.20172.86
25.04.20172.89
18.04.20172.92
11.04.20173.00
04.04.20173.29
28.03.20173.61
21.03.20173.35
14.03.20173.57
07.03.20173.64
28.02.20173.58
21.02.20174.36
14.02.20174.60
07.02.20174.43
31.01.20174.76
24.01.20174.50
17.01.20174.72
10.01.20175.13
03.01.20174.78
27.12.20164.92
19.12.20165.05
12.12.20165.29
05.12.201638.10
28.11.201634.54
21.11.201636.11
14.11.201635.87
07.11.201632.33
31.10.201635.82
24.10.201635.24
17.10.201638.15
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
2.63n/a
Market Capitalisation
in million USD
94n/a
Enterprise Value
in million USD
-205n/a
Common Shares Outstanding
as per Aug 1, 2016
35,593,176n/a
Preferred Shares Outstanding
as per Aug 1, 2016
n/a
Average Basic Shares Outstanding
TTM
35,115,250n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 52n/a
Gross Profit 52n/a
Operating Income -156n/a
EBITDA -155n/a
Net Profit -141n/a
Balance Sheet
Cash and Cash Equivalents 299n/a
Receivables 0n/a
Total Current Assets 355n/a
PP&E 3n/a
Total Assets 386n/a
Accounts Payable 8n/a
Current Debt 0n/a
Total Current Liabilities 40n/a
Long-Term Debt 0n/a
Total Liabilities 371n/a
Total Equity 15n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital -31n/a
Operating Cash Flow -133n/a
Net Change in PP&E and Intangibles -2n/a
Investing Cash Flow 278n/a
Dividends Paid 0n/a
Financing Cash Flow 12n/a
Total Change in Cash 157n/a
Free Cash Flow -176n/a
Profitability Ratios
Gross Margin 100.0%n/a
Operating Margin -299.0%n/a
Net Profit Margin -271.3%n/a
Return on Equity -975.3%n/a
Return on Assets -36.7%n/a
Per Share Figures
Basic EPS -4.03n/a
Diluted EPS n/a
Sales per Share 1.49n/a
Book Value per Share 0.41n/a
FCF per Share -5.00n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -0.65n/a
Price to Sales Ratio 1.77n/a
Price to Book Value 6.37n/a
Price to Free Cash Flow -0.53n/a
Valuation Metrics
EV/EBITDA 1.32n/a
EV/Sales -3.93n/a
Book to Market Value 0.16n/a
Other Ratios
Current Ratio 894.5%n/a
Liabilities to Equity Ratio 2,560.1%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Revenue
0
0
0
41
52
Sales & Services Revenue
0
0
0
0
0
Financing Revenue
0
0
0
0
0
Other Revenue
0
0
0
0
0
Cost of revenue
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
Gross Profit
0
0
0
41
52
Other Operating Income
0
0
0
0
0
Operating Expenses
-20
-14
-47
-122
-175
Selling, General & Administrative
-6
-7
-14
-33
-44
Selling & Marketing
0
0
0
0
0
General & Administrative
0
0
0
0
0
Research & Development
-14
-7
-33
-88
-131
Depreciation & Amortization
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
Operating Income (Loss)
-20
-14
-47
-81
-124
Non-Operating Income (Loss)
0
-1
-3
0
1
Interest Expense, net
0
-1
-1
0
1
Interest Expense
0
0
0
0
0
Interest Income
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
-1
0
0
Pretax Income (Loss), Adjusted
-20
-15
-50
-80
-123
Abnormal Gains (Losses)
0
0
-1
0
0
Acquired In-Process R&D
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
Sale of Business
0
0
0
0
0
Legal Settlement
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
Pretax Income (Loss)
-20
-15
-51
-80
-123
Income Tax (Expense) Benefit, net
1
0
0
-36
17
Current Income Tax
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
Income (Loss) from Continuing Operations
-19
-15
-51
-117
-106
Net Extraordinary Gains (Losses)
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
Income (Loss) Including Minority Interest
-19
-15
-51
-117
-106
Minority Interest
0
0
0
0
0
Net Income
-19
-15
-51
-117
-106
Preferred Dividends
-7
-7
-6
0
0
Other Adjustments
0
0
0
0
0
Net Income Available to Common Shareholders
-25
-22
-57
-117
-106
Remarks
restated on Mar 11, 2014 n/a
calculated values,
restated on Jul 28, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
Balance SheetBS data quality: 96% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
4
211
464
297
Cash & Cash Equivalents
n/a
4
211
40
222
Short Term Investments
n/a
0
0
424
75
Accounts & Notes Receivable
n/a
0
0
0
0
Accounts Receivable, Net
n/a
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
Inventories
n/a
0
0
0
0
Raw Materials
n/a
0
0
0
0
Work In Process
n/a
0
0
0
0
Finished Goods
n/a
0
0
0
0
Other Inventory
n/a
0
0
0
0
Other Short Term Assets
n/a
0
7
10
10
Prepaid Expenses
n/a
0
7
9
2
Derivative & Hedging Assets
n/a
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
3
Discontinued Operations
n/a
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
1
4
Total Current Assets
n/a
4
217
473
306
Property, Plant & Equipment, Net
n/a
0
0
2
3
Property, Plant & Equipment
n/a
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
95
Long Term Investments
n/a
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
Other Long Term Assets
n/a
0
0
5
24
Intangible Assets
n/a
0
0
0
0
Goodwill
n/a
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
Deferred Tax Assets
n/a
0
0
5
23
Derivative & Hedging Assets
n/a
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
Total Noncurrent Assets
n/a
1
0
6
122
Total Assets
n/a
5
218
480
429
Liabilities and owners' equity
Payables & Accruals
n/a
2 2404000
6 6295000
17 16625000
31 30838000
Accounts Payable
n/a
1 1391000
4 3810000
9 8707000
12 12018000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
1 1013000
2 2485000
8 7918000
19 18820000
Short Term Debt
n/a
11 11040000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
1 966000
0 0
3 3206000
7 6667000
Deferred Revenue
n/a
0 0
0 0
3 3206000
7 6667000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
1 966000
0 0
0 0
0 0
Total Current Liabilities
n/a
14 14410000
6 6295000
20 19831000
38 37505000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
-13 -12532000
42 41667000
331 331418000
331 331399000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
206 206418000
206 206399000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
-13 -12532000
42 41667000
125 125000000
125 125000000
Total Noncurrent Liabilities
n/a
-13 -12532000
42 41667000
331 331418000
331 331399000
Total Liabilities
n/a
2 1878000
48 47962000
351 351249000
369 368904000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
0 1000
353 352770000
428 428424000
466 465959000
Common Stock
n/a
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
Retained Earnings
n/a
0 0
-183 -183050000
-300 -299822000
-406 -405539000
Other Equity
n/a
0 0
0 0
0 -65000
0 -473000
Equity Before Minority Interest
n/a
0 1000
170 169720000
129 128537000
60 59947000
Minority Interest
n/a
0 0
0 0
0 0
0 0
Total Equity
n/a
0 1000
170 169720000
129 128537000
60 59947000
Total Liabilities & Equity
n/a
2 1879000
218 217682000
480 479786000
429 428851000
Remarks restated on n/a restated on Mar 11, 2014 n/a restated on Jul 28, 2015 n/a restated on Feb 26, 2016 n/a restated on Aug 5, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-19
-15
-51
-117
-106
Net Income
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
1
Non-Cash Items
1
1
5
11
9
Stock-Based Compensation
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
Change in Working Capital
-1
0
-3
217
18
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
Cash from Operating Activities
-19
-13
-49
111
-79
Change in Fixed Assets & Intangibles
0
0
0
-2
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
Net Change in Long Term Investment
3
0
0
-426
250
Decrease in Long Term Investment
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
Cash from Investing Activities
3
0
0
-428
248
Dividends Paid
0
0
0
0
0
Cash From (Repayment of) Debt
15
11
213
55
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
3
11
Increase in Capital Stock
0
0
0
3
11
Decrease in Capital Stock
0
0
0
0
0
Other Financing Activities
0
0
42
88
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
Cash from Financing Activities
15
11
255
146
13
Net Cash Before Disc. Operations and FX
-1
-2
206
-171
182
Change in Cash from Disc. Operations and Other
0
0
0
0
0
Net Cash Before FX
-1
-2
206
-171
182
Effect of Foreign Exchange Rates
0
0
0
0
0
Net Changes in Cash
-1
-2
206
-171
182
Remarks
restated on Mar 11, 2014 n/a
calculated values,
restated on Jul 28, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo